Lv77
4110 积分 2021-04-25 加入
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
11天前
已完结
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease
23天前
已完结
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
23天前
已关闭
Coagulation and fibrinolysis in gastric cancer
1个月前
已完结
Survival outcome after surgery in patients with thymoma distant recurrence
2个月前
已完结
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
2个月前
已完结
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
2个月前
已完结
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)
2个月前
已完结
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
2个月前
已完结
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
2个月前
已完结
皖公网安备34019202002308
